Biogen Company

Biogen Eisai’s Alzheimer’s drug Leqembi rejected by European regulator

European drug regulators on Friday discarded object Alzheimer’s disease treatment Leqembi from Biology And Eisaicreating another barrier for companies as…

Read More »